Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

TherapeuticsMD Inc logo

TherapeuticsMD Inc

US$2.11

US$24.4m

4.46%

72.87%

Dashboard Funda..tals Deep..lue Prediction Screener Map

TherapeuticsMD Inc Overview

Industry: Drug Manufacturers Specialty & Generic

Sector: Healthcare

TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

TherapeuticsMD Inc is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review TherapeuticsMD Inc in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



TherapeuticsMD Inc Competitors

TherapeuticsMD Inc operates in the Drug Manufacturers Specialty & Generic industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

TherapeuticsMD Inc

US$2.11

US$24.4m

4.46%

72.87%